Cargando...
Finding new lanes: Chimeric antigen receptor (CAR) T‐cells for myeloid leukemia
BACKGROUND: Myeloid leukemia represents a heterogeneous group of cancers of blood and bone marrow which arise from clonal expansion of hematopoietic myeloid lineage cells. Acute myeloid leukemia (AML) has traditionally been treated with multi‐agent chemotherapy, but conventional therapies have not i...
Gardado en:
| Publicado en: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941581/ https://ncbi.nlm.nih.gov/pubmed/32671999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1222 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|